Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
Male
0301 basic medicine
Science
Programmed Cell Death 1 Receptor
Antibodies, Monoclonal, Humanized
Article
Mice
03 medical and health sciences
Drug Delivery Systems
Cell Line, Tumor
Animals
Humans
Immune Checkpoint Inhibitors
Microbubbles
Brain Neoplasms
Q
Brain
Glioma
Mice, Inbred C57BL
Ultrasonic Waves
Doxorubicin
Blood-Brain Barrier
Female
Microglia
Glioblastoma
DOI:
10.1038/s41467-024-48326-w
Publication Date:
2024-06-06T10:03:47Z
AUTHORS (33)
ABSTRACT
Abstract Given the marginal penetration of most drugs across blood-brain barrier, efficacy various agents remains limited for glioblastoma (GBM). Here we employ low-intensity pulsed ultrasound (LIPU) and intravenously administered microbubbles (MB) to open barrier increase concentration liposomal doxorubicin PD-1 blocking antibodies (aPD-1). We report results on a cohort 4 GBM patients preclinical models treated with this approach. LIPU/MB increases by 2-fold 3.9-fold in human murine brains two days after sonication, respectively. Similarly, LIPU/MB-mediated disruption leads 6-fold aPD-1 concentrations peritumoral brain regions from pembrolizumab, Doxorubicin delivered upregulate major histocompatibility complex (MHC) class I II tumor cells. Increased achieved elicit IFN-γ MHC expression microglia macrophages. long-term survival glioma-bearing mice, which rely myeloid cells lymphocytes their efficacy. Overall, translational study supports utility potentiate antitumoral activities GBM.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (78)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....